Preparation,characterization, and antitumor activity of new cisplatin analogues with 1-methyl-4-(methylamino)piperidine: crystal structure of [PtII(1-methyl-4-(methylamino) piperidine)(oxalate)

A series of new platinum(II) complexes of the type [Pt(II)(mmap)X] (where mmap, 1-methyl-4-(methylamino)piperidine and X, 1,1-cyclobutanedicarboxylato (CBDCA), oxalato, malonato, methylmalonato, dimethylmalonato, ethylmalonato, diethylmalonato or 2,3-naphthalene dicarboxylato (NDCA)) have been synthesized and characterized by elemental analysis, infrared (IR), and 13C and 195Pt nuclear magnetic resonance (NMR) spectroscopy. The crystal structure of the analogue [Pt(II)(mmap)(oxalate)] was determined using the single crystal X-ray diffraction method. Based upon a total of 4964 collected reflections, we determined that the compound crystallizes in the monoclinic space group P2(1)/c (with a=11.890(2) A, b=9.6695(19) A, c=9.875(2) A, beta=102.03(3) degrees, Z=4, and R=0.0428). In this complex, platinum has a slightly distorted square planar geometry with the two adjacent corners being occupied by two nitrogen atoms of the mmap ligand, whereas the remaining cis positions are occupied by two oxygen atoms of the oxalate molecule. The mmap ligand is in a boat conformation and forms six-membered chelating rings as well as the oxalate molecule forms five-membered chelating rings with platinum. The complexes were evaluated for their cytotoxic potential against the sensitive A2780 tumor model and cisplatin-resistant clone derived in vitro from potential cells.     

Synthesis and characterization of technetium(V) complexes with tridentate schiff base ligands. X-ray crystal structure of chloro[N-(2-hydroxyphenyl)salicylideneiminato]oxotechnetium(V)

Five-coordinate technetium(V) complexes of the form TcO(L)Cl where L is one of the two tridentate Schiff base ligands N-(2-oxidophenyl)salicylideneiminate or N-(2-mercaptophenyl)salicylideneiminate have been synthesized and characterized. These neutral complexes precipitate from methanol upon reaction of the Schiff base ligand with TcOCl₄^?. A single crystal X-ray structure determination shows that the chloro [[N-(2-oxidophenyl)salicylideneiminato](2?)-N,O,O′]oxotechnetium(V) complex, [TcO(C₁₃H₉NO₂)Cl], formula weight 362, has a distorted square pyramidal coordination geometry with the oxo ligand in the axial position. The steric requirements of the oxo group cause the Tc atom to be displayed 0.67 Å out of the mean equatorial plane of the other four donor atoms. This complex crystallizes in the monoclinic space group P2₁/a with a = 13.423(6) Å, b = 12.570(5) Å, c = 7.769(3) Å, β = 106.53(5)°, V = 1256.7(9) ų, and Z = 4. The structure has been refined to R = 0.047 for 1775 observed reflections.     

Coordination chemistry of 7,9-disubstituted 6-oxopurine metal compounds. 4. Platinum(II) coordination at N(1). Molecular and crystal structure of [(ethylenediamine)bis(7,9-dimethylhypoxanthine)platinum(II)] hexafluorophosphate

The preparation and molecular and crystal structure of the complex [(ethylenediamine)bis(7,9,-dimethylhypoxanthine)platinum(II)] hexafluorophosphate, [Pt(C₂H₈N₂)(C₇H₈N₄O)₂] (PF₆)₂, are reported. The complex crystallizes in the monoclinic system, space group C2/c, with a = 12.334(2)Å, b = 10.256(2)Å, c = 22.339(3)Å, β = 101.31(1)°, V = 2771.0ų, Z = 4, D_measd = 2.087(3) g cm^?3, D_calc = 2.094 g cm^?3. Intensities for 3992 symmetry-averaged reflections were collected in the θ-2o scan mode on an automated diffractometer employing graphite-monochromatized MoKα radiation. The structure was solved by standard heavy-atom Patterson and Fourier methods. Full matrix least-squares refinement led to a final R value of 0.051. Both the ethylenediamine chelate and the PF₆^? anion are disordered. The primary coordination sphere about the Pt(II) center is approximately square planar with the bidentate ethylenediamine ligand and the N(1) atoms [Pt(II) ? N(1) = 2.020(5)Å] of two 7,9-dimethylhypoxanthine bases (related by a crystallographic twofold axis of symmetry) occupying the four coordination sites. The exocyclic O(6) carbonyl oxygen atoms of the two 7,9-dimethylhypoxanthine ligands participate in intracomplex hydrogen bonding with the amino groups of the ethylenediamine chelate [N(ethylenediamine) ? O(6) = 2.89( )Å]. The observed Pt ? O(6) intramolecular distances of 3.074(6)Å are similar to those found in other Pt(II) N(1)-bound 6-oxopurine complexes and in several Pt(II) N(3)-bound cytosine systems.     

Antibodies against (1R,2R)-cyclohexanediamineplatinum(II)-DNA adduct recognize the conformational differences of isomeric analogues of cyclohexanediamine

Antibodies reactive to (1R,2R)-cyclohexanediamineplatinum(II)-DNA ((1R,2R)-cyclohexanediamine: 1R,2R-dach) adducts were elicited by immunization of rabbit with calf thymus DNA modified by Pt(1R,2R-dach)Cl2 at a ratio of bound platinum per nucleotide ((D/N)b) of 0.0335. In an enzyme-linked immunosorbent assay (ELISA), the binding of specific antibodies to Pt(1R,2R-dach)-DNA adduct (60 microliters of 1.235 x 10(-7) M Pt in each wells) on the assay plate was competitively inhibited by Pt(1R,2R-dach)-DNA adduct ((D/N)b = 0.0653) in the solution. Almost equal inhibition was observed with Pt(1S,2S-dach)-DNA ((D/N)b = 0.0412), an optical isomer of 1R,2R-dach. Pt(1R,2S-dach)-DNA ((D/N)b = 0.0371) and Pt(1R,3S-dach)-DNA ((D/N)b = 0.0281) in which the cyclohexane ring is stereochemically perpendicular to the platinum chelate plane, also inhibited antibody binding, but these adducts gave only incomplete inhibition at higher Pt-DNA adduct concentrations. Although Pt(1R,2R-dach)-d(GpG) and Pt(1R,2R-dach)(NH3)2 inhibited antibody binding, the affinity of the antibody for Pt(1R,2R-dach)(NH3)2 was lower than with Pt(1R,2R-dach)-DNA, and the inhibition behavior of Pt(1R,2R-dach)-d(GpG) was biphasic, i.e., at the lower concentration the inhibition curve was consistent with that of Pt(1R,2R-dach)-DNA, but at the higher concentration it shifted to that of Pt(1R,2R-dach)(NH3)2. The affinity of the antibody for cis-DDP was markedly lower than with Pt(1R,2R-dach)(NH3)2. These facts suggest that the antibodies may bind to the substituents (the platinum and its surroundings) of the various Pt complexes rather than the DNA structure altered by platinum binding.     

Spectroscopic and structural investigation of two (2,2′-bipyridyl)bis(N-protected-aminoacidato)copper(II) complexes,two compounds containing truly CuN2O2 chromophore

The compounds of formula [Cu(bipy)(acleuO)₂] (1) and [Cu(bipy)(ts-β-alaO)₂] (2) (bipy = 2,2′-bipyridil, acleuO = N-acetyl-DL-leucinate anion, ts-β-alaO = N-tosyl-β-alaninate anion) were synthesized and characterized by means of spectroscopic and structural measurements. Complex (1) crystallizes in the monoclinic space group C2/c with cell parameters a = 17.465(4), b = 19.740(5), c = 9.080(2) Å, β = 115.0(1)° with Z = 4; complex (2) crystallizes in the triclinic space group P$\text{1}$, with cell parameters a = 14.489(3), b = 14.308(3), c = 8.659(1) Å, α = 75.0(1), β = 74.6(1), γ = 66.6(1)°, Z = 2. Both structures were solved by conventional Patterson and Fourier methods and refined to R factors of 4.10 and 3.8% respectively. In both crystals the Cu atom is four-coordinated by the nitrogen atoms of a bipy molecule and two carboxylate oxygens of two N-protected aminoacid anions acting as unidentate ligands. The only significant difference between the coordination geometry of (1) and (2) is in the tetrahedral distortion of the coordination plane. Complex (2) is strictly planar, while in complex (1) the distortion expressed by the dihedral angle between the (N)(1)CuN(1′) and O(1)CuO(1′) planes is 20.8°. The electronic and EPR results agree with these different coordination geometries. The infra-red data are consistent with a truly monodentate carboxylate group. The spectroscopic results on a series of previously investigated [Cu(bipy)(N-protected aminoacidato)²] complexes of unknown structures are discussed again in the light of the present structural reports.     

Crystal and molecular structure of the (2,2′-diaminobiphenyl)(R,R-trans-1,2-diaminocyclohexane)platinum(II) complex

2,2′-Diaminobiphenyl-R,R-trans-1,2-diaminocyclohexaneplatinum(II) Chloride Trihydrate, (R,R-chxn)(dabp)Pt]Cl₂·3H₂O, crystallizes in the space group _p2₁2₁2₁ (D₂⁴, No. 19) with a = 6.219(4) Å, b = 17.633(2) Å, c = 21.523(3) Å, V = 2,360.4(8) ų, ?_calcd = 1.739 g cm^?3, ?_measd = 1.74 g cm^?3, and Z = 4. Diffraction data were collected with a Picker FACS-1 four-circle diffractometer. The structure was solved by the heavy atom method and refined by least-square calculations to residuals R = 0.0586 and weighted R = 0.0668. The 2,2′-diaminobiphenyl ligand exhibits complete stereospecificity in its coordination to platinum(II) ion with λ chiral conformation.     

Pt(II) compounds with sulfoxide ligands and crystal structures of complexes of the types I(R2SO)Pt(μ-I)2Pt(R2SO)I and trans-Pt(R2SO)(L)X2 (L = amine,pyridine and pyrimidine)

The crystal structures of several Pt(II) complexes containing sulfoxide ligands are described. The two iodo bridged dimers of the type I(R₂SO)Pt(μ-I)₂Pt(R₂SO)I (where R is ethyl or n-butyl) are twinned structures. The dinuclear species are the trans isomers. Two compounds of the type trans-Pt(DMSO)(amine)X₂ were studied by X-ray diffraction methods. The diiodo MeNH₂ compound forms H-bonded chains, formed by maximizing the H-bonds between the amine group with the O atom of DMSO and one iodo ligand. The H-bonding pattern is quite different in the dichloro t-BuNH₂ complex. In the latter crystal, there are two independent molecules which are H-bonded in pairs. The methyl groups of DMSO and the t-butyl group of the amine are oriented towards the outside of the pairs of molecules, while the H-bonds link the two independent molecules. Again, the amino group forms the maximum H-bonds with the O atom of DMSO and one chloro ligand. The crystal structures of trans-Pt(DMSO)(pyridine)I₂ and of trans-Pt(MeBzSO)(pyrimidine)I₂ (Bz = benzyl) were also studied. In the pyridine complex, the O atom of DMSO is in the Pt(II) plane by symmetry, while in the pyrimidine compound, the C atom of the –CH₃ group is in the Pt(II) plane. The pyridine and the pyrimidine ligands are perpendicular to the Pt(II) square plane. The trans influence of the different ligands is discussed.     

Preparation and structural characterization of di-μ-azido-bis[azido(2-aminopyridine)aquo]dicopper(II), [Cu(2-ampy)(N3)2(H2O)]2

Di-μ-azido-bis[azido(2-aminopyridine)aquo]dicopper(II), [Cu(2-ampy)(N₃)₂(H₂O)]₂, was synthesized and characterized by X-ray crystallography. The crystals are triclinic, space group P$\text{1}$, with a = 7.142(1), b = 7.812(1), c = 9.727(1) Å, a = 96.52(1), β = 95.52(1), γ = 113.47(1)°, and Z = 1. The structure was refined to R_F = 0.030 for 1960 observed MoKα diffractometer data. The dimeric molecule, which possesses a crystallographic inversion center, contains both terminal and μ(1)-bridging azido groups. Each copper(II) atom is further coordinated by a 2-aminopyridine ligand (via its ring N atom) and a water molecule to give a distorted square pyramid, with the metal atom raised by 0.17 Å above the N₄ basal plane [CuN (ring) = 2.001(2), CuN (azide) = 1.962(3)–2.018(2) Å] towards the apical aquo ligand [CuO = 2.371(2) Å]. Each water molecule forms an intramolecular O?HN (amine) acceptor hydrogen bond, and is linked by two OH?N (terminal azide) intermolecular donor hydrogen bonds to adjacent dimeric complexes to yield a layer structure parallel to (001). Infrared and electronic spectral data are presented and discussed.     

31P and 195Pt NMR studies on the clusters [Pt4(μ2-CO)5L4]. L = PEt3, PMe2Ph,PMePh2, PEt2But. The molecular structure of a monoclinic modification of [Pt4(μ2-CO)5(PMe2Ph)4].

Several clusters complexes of composition [Pt₄(μ₂-CO)₅L₄] have been synthesized and characterized, using ³¹P and ¹⁹⁵Pt NMR. L = PEt₃, PMe₂Ph, PMePh₂, PEt₂Bu^t. The molecular structure of a new monoclinic modification of the PMe₂Ph derivative has been determined: space group P2₁/n with a = 19.698(4), b = 10.9440(20), and c = 21.360(6) Å, β = 112.432(18)°, Z = 4. Using 4751 reflections measured at 290 ± 1 K on a four-circle diffractometer the structure has been refined to R = 0.0846. The molecule has no imposed symmetry, but the central Pt₄(CO)₅P₄ core has the approximate C₂v architecture established for the previously known orthorhombic modification. The Pt₄ unit is thus a highly distorted, edge-opened (3.3347 Å) tetrahedron, with five edge-bridging carbonyl and four terminal phosphine ligands. In contrast to the crystallographic results ³¹P and ¹⁹⁵Pt NMR spectra reveal equivalent ³¹P and ¹⁹⁵Pt spins, which can be interpreted in terms of a tetrahedral arrangement of platinum atoms. It is suggested that this equivalence arises from time-averaging of all possible isomeric edge-opened tetrahedra.     

Metal ions-nucleobases interactions: preparation and crystal structures of trichloroadeninium zinc(ii)(form ii) and a similar zinc complex of arprinocid [6-amino-9-(2-chloro-6-fluorobenzyl)purine]

Two zinc complexes—trichloroadeninium zinc(II)(Form 11), C₅H₆N₅Cl₃Zn [structure(I)] and a similar complex of Arprinocid, (6-amino-9-(2-chloro-6-fluorobenzyl)purine], C₁₂H₁₀N₅FCl₄Zn [structure(II)]—have been prepared Structure(I) crystallizes in the space group P2₁/c with a = 8.223(1)Å, b = 6.755(1) Å, c = 18.698(3) Å, β = 96.10(2)°,and Z = 4. Structure(II) crystallizes in the space group P2₁/c with a = 8.209(2) Å, b = 6.421(8) Å, c = 31.794(8) Å, β = 90.76(2)°, and Z = 4. Both of these structures were solved by the heavy atom method using diffractometric data and refined to R = 0.028 [structure(I)] and 0.038 [structure(II)]. Zinc with a distorted tetrahedral coordination having three chlorines and N(7) as ligators, protonation of the adenine moiety at N(1), dissymmetry of exocyclic angles at N(7), and an interligand hydrogen bond (“indirect chelation”) involving one of the three chlorines, coordinated to zinc and a proton of the exocylic amino group are the striking features common to both structures. Similar types of indirect chelation as observed in the different complexes of purines have been discussed. The zinc ion deviates from the imidazole plane by 0.412 Å in structure(I) and 0.524 Å in Structure(II). The imidazol and pyrimidine planes fold about the C(4)-C(5) bond by 2.4° in strctur(I) and 3.8° in structure(II). In structure(I), inversion related molecules are paired through N(9)-H…N(3) hydrogen bonds. N-H…Cl hydrogen bonds and C(8)-H…Cl interactions have been observed in both structures.     

The crystal and molecular structures of dichloro [N,O-(D,L)-diaminopropionic acid] platinum(II) and Dichloro [N,O-(L)-lysine] platinum(II) monohydrate

K₂PtCl₄ reacts with L-lysine and with D,L-diaminiopropionic acid (Dap) forming the neutral complexes [PtCl₂(N,O-Lys)]·H₂0 (1) and [PtCl₂(N,O-Dap)], (2) respectively.Compound 1 is monoclinic, space group P2₁ with a = 11.262(3), b = 11.041(2), c = 9.690(2) Å, β = 102.07(5)°, V = 1178(1) ų and Z = 4. Compound 2 is monoclinic, space group P2₁/n with a = 8.777(1), b = 10.615(2), c = 7.947(1) Å, β = 94.98(3)°, V = 738(1) ų and Z = 4. In both compounds, the zwitterionic ligands form an N,O-five membered chelate with the platinum atom. Structures 1 and 2 were refined to R values of 3.3% and 6.3% respectively.     

Monomeric molybdenum(V) complexes. 4. The structure of tetraphenylarsonium oxodichloro(N-2-oxophenylsalicylideniminato)molybdate(V), [Ph4As] [MoOCl2(SalphO)]

The structure of [Ph₄As] [MoOCl₂(SalphO)], where SalphO is N-2-oxophenylsalicylideniminate dianion, has been determined by X-ray crystallography. The complex crystallizes in the monoclinic space group P2₁/n with a = 11.829(2), b = 16.149(3), c = 17.410(3) Å, β = 97.485(15)° and Z = 4. The calculated and observed densities and 1.566 and 1.573(10) g cm^?3, respectively. Block-diagonal least-squares refinement of the structure using 4722 independent reflections with I ? 3σ(I) converged at R = 0.0345 and R_w = 0.0484. The crystal contains [Ph₄As]⁺ cations and [MoOCl₂(SalphO)]^? anions. The Mo atom in the anion is in a distorted octahedral coordination environment. A planar terdentate Schiff base ligand occupies meridional positions with the N atom trans to the terminal oxo group (O_t). Two Cl atoms are cis to the O_t atom. The Mo atom is displaced by 0.33 Å from the equatorial plane toward the O_t atom. The MoO_t distance is 1.673(3) Å. The MoN bond trans to the O_t atom is 2.298(4) Å. The two MoCl bond lengths are 2.371(1) and 2.408(1) Å. The difference of 0.037 Å is significant (30 σ). Preparations of the title complex and the related complexes are also described.     

Cyclic AMP inhibition of protein kinase activity in HeLa 65 plasma membranes.

Demethylisothiocolchicine forms monoclinic crystals, space group P2₁, a = 11.906, b = 8.713, c = 10.004 Å; β = 89.44°; Z = 2. The crystal and molecular structure was determined from 1911 independent x-ray reflections and refined to R = 0.04. The molecule has the same overall shape as active colchicine derivatives but one methoxy group has a different conformation from that found in other compounds.     

Mononuclear rhodium(I) complexes of 4-Amino-3,5-bis(pyridin-2-yl)-1,2,4-triazole. Crystal structure of [Rh(CO)2(NH2bpt)]ClO4

Reaction of 4-amino-3,5-bis(pyridin-2-yl)-1,2,4-triazole (NH₂bpt) or its potassium salt (KNHbpt) with several rhodium(I) compounds, produces new neutral and cationic complexes of Rh(I). One of the complexes [Rh(CO)₂(NH₂bpt)]ClO₄ has been characterized by single-crystal X-ray diffraction. The crystals are monoclinic, space group P2₁/n, with a = 17.6130(6), b = 11.3072(2), c = 9.0013(2) Å, β = 101.536(2)° and Z = 4. The structure has been refined to R = 0.049.     

Preparation of platinum(II) complexes with L-serine using KI. X-ray crystal structure, HPLC and 195Pt NMR spectra

The preparation of platinum(II) complexes containing L-serine using K(2)[PtCl(4)] and KI as raw materials was undertaken. The cis-trans isomer ratio of the complexes in the reaction mixture differed significantly depending on whether KI was present or absent in the reaction mixture. One of the two [Pt(L-ser-N,O)(2)] complexes (L-ser=L-serinate anion) prepared using KI crystallizes in the monoclinic space group P2(1)2(1)2(1) with unit cell dimensions a=8.710(2) A, b=9.773(3) A, c=11.355(3) A, Z=4. The crystal data revealed that this complex has a cis configuration. The other [Pt(L-ser-N,O)(2)] complex also crystallizes in the monoclinic space group P2(1)2(1)2(1) with unit cell dimensions a=7.0190(9) A, b=7.7445(6) A, c=20.946(2) A, Z=4. The crystal data revealed that this complex has a trans configuration. The 195Pt NMR chemical shifts of trans-[Pt(L-ser-N,O)(2)] and cis-[Pt(L-ser-N,O)(2)] complexes are -1632 and -1832 ppm, respectively. 195Pt NMR and HPLC measurements were conducted to monitor the reactions of the two [Pt(L-ser-N,O)(2)] complexes with HCl. Both 195Pt NMR and HPLC showed that the reactivities of cis- and trans-[Pt(L-ser-N,O)(2)] toward HCl are different: coordinated carboxyl oxygen atoms of trans-[Pt(L-ser-N,O)(2)] were detached faster than those for cis-[Pt(L-ser-N,O)(2)].     

New preparations and molecular structures of cis-MCl2(Ph2PCH2PPh2)2, M = Ru,Os and trans-RuCl2(Ph2PCH2PPh2)2

The title compounds were made by reacting bis(diphenylphosphino)methane (dppm) with reduced solutions of OsCl₆^4? and Ru₂OCl₁₀^4?. The crystal and molecular structures of these compounds have been determined form three-dimensional X-ray study. The cis-isomers crystallize with one CHCl₃ per molecule of the complex. All three compounds crystallize in the monoclinic space group P2₁/n with unit cell dimensions as follows: Cis-OsCl₂(dppm)₂·CHCl₃: a = 13.415(4) Å, b = 22.859(4) Å, c = 16.693(3) Å, β = 105.77(3)°, V = 4926(3) ų, Z = 4. cis-RuCl₂(dppm)₂·CHCl₃: a = 13.442(3) Å, b = 22.833(7) Å, c = 16.750(4) Å, β = 105.53(2)°, V = 4953(3) ų, Z = 4. trans-RuCl₂(dppm)₂: a = 11.368(7) Å, b = 10.656(6) Å, c = 18.832(12) Å; β = 103.90(6)°, V = 2213(7) ų; Z = 2. The structures were refined to R = 0.044 (R_w = 0.055) for cis-OsCl₂(dppm)₂·CHCl₃; R = 0.065 (R_w = 0.079) for cis-RuCl₂(dppm)₂·CHCl₃ and R = 0.028 (R_w = 0.038) for trans-RuCl₂(dppm)₂. The complexes are six coordinate with stable four-membered chelate rings. The PMP angle in the chelate rings is ca. 71° in each case.     

Synthesis and characterization of complexes containing the bis(1, 2-diolato)-oxotechnetium(V) core

The complexes (Bu₄N)[TcO(O₂C₆H₄)₂] (1) and Na[TcO(OCH₂CH₂O)₂] (2) have been prepared by reacting TcOCl₄^- with respective diols in methanol. Compound 2 was identified by its elemental analysis and field desorption mass spectrum. Crystals of compound 1 are monoclinic, C2/c, with cell dimensions a = 10.393(3), b = 13.835(3), c = 20.643(5) Å, β = 101.74(3)° and four formula units in the unit cell. The crystal structure was determined by standard methods and refined to R₁ = 0.0694, R₂ = 0.0613, on the basis of 2887 independent reflections. The data were collected with use of Mo Kα radiation and a Syntex P2₁ diffractometer. The anion of 1 is square pyramidal with a short TcO(oxo) bond (1.648(5) Å). TcO distances to the diolate groups are longer (1.956(3), 1.958(3) Å). The technetium atom lies 0.7014(4) Å out of the plane of the four diolate oxygen atoms. Compound 2 is hydrolytically unstable in pure water, but can be stabilized by the addition of a several-fold molar excess of ethylene glycol. Compound 1 decomposes minimally in pure water after 24 h. These complexes are shown to be good structural models for ^99mTc-radiopharmaceuticals containing purely oxygen-donor ligands. Comparison of the physical properties of the structurally characterized members of the series of complexes with core structures TcOS_xO_(4-x) (x = O, 2, 4) shows a shift to low energy in the frequency of the terminal oxygen-technetium band in the IR correlated with increasing softness of the basal plane donor atom set.     

Triboluminescence and crystal structure of the centrosymmetric complex [Tb(NO3)2(Acac)(Phen)2]·H2O

The atomic structure of crystals of the complex [Tb(NO₃)₂(Acac)(Phen)₂]·H₂O, (AA – acetylacetonate anion, Phen – 1,10‐phenanthroline) characterized by an intensive luminescence and triboluminescence has been determined by means of an X‐ray structural analysis method. Centrosymmetric crystals have a monoclinic syngony: a = 11.2298(1), b = 9.6492(1), c = 13.2745(1) Å, β = 101.290(1), space group P2/n, Z = 2, ρ_calc = 1.790 g/cm³. The crystal structure is represented by individual С₂₉Н₂₅N₆O₉Tb complexes linked through van der Waals interactions with clearly expressed cleavage planes. The Tb(III) atom coordination polyhedron reflects the state of a distorted square antiprism. The structural aspects of the suggested model of formation of the triboluminescent properties were considered and the role of the cleavage planes discussed. Copyright © 2016 John Wiley & Sons, Ltd.     

Crystal and molecular structure of Δ-cis-α-ethylenebis-S-prolinato(1,2-diamino-ethane)cobalt(III) perchlorate dihydrate, Δ-cis-α-[Co(ss-EBP)(en)] ClO4·2H2O

The crystal and molecular structure of Δ- cis-α- ethylenebis-S-prolinato(1,2-diaminoethane)cobalt(III) perchlorate dihydrate, Δ-cis-α-[Co(SS-EBP)(en)] ClO₄· 2H₂O, was determined from three-dimensional X-ray diffractometer data. The complex crystallizes in the orthorhombic system, space group P2₁2₁2₁ with a = 7.879(4) Å, b = 13.738(9) Å, c = 19.445(2) Å, V = 2104(2) ų. With Z = 4, the observed and calculated densities are 1.60(2) and 1.605 g cm^?3, respectively. The structure was refined by the block- diagonal least-squares technique to a final R = 0.0560 for 1604 observed reflections. The geometry about the cobalt atom is roughly octahedral with the tetradentate SS-EBP (= ethylenebis-S-prolinate ion), assuming cis-α configuration in which the complex possesses two out-of-plane amino acidate (R) rings and the backbone ethylenediamine (E) ring. The E ring conformation is δ. On the other hand, the R rings have λ conformation as well as the en ring. Δ-R_NR_N?(δ_E  λ_R1  λ_R2)(λ_en)-cis-α-[Co(SS-EBP)(en)]⁺ is one of two possible isomers of this compound which have been isolated and whose absolute configurations have been tentatively assigned by spectroscopy. The crystal and molecular structure determination confirms these assignments.     

Caffeine complexes of platinum(II): crystal structure of cis-[Pt(C8H10N4O2)2Cl2]·0.4H2O

The preparations are reported of cis[Pt(caffeine)₂Cl₂]·0.4H₂O, Pd(caffeine)₂Cl₂, the methanol adduct of the previously known compound K[Pt(caffeine)Cl₃], and Pt(caffeine)(cytidine)Cl₂. Crystals of [Pt(caffeine)₂Cl₂]·0.4H₂O are tetragonal P4₂/n with a = 13.156(2) 0?, c = 12.734(2) 0?, Z = 4. The structure was refined on 945 reflections to R = 0.025. The molecule is cis with a crystallographic two-fold axis bisecting the ClPtCl and NPtN angles. The Pt is square planar with PtN and PtCl bonds of 2.029(5) Å and 2.271(2) Å respectively. There is a 5.4° dihedral angle between the imidazole and pyrimidine rings, and the imidazole ring is rotated away from the coordination plane by 86.4°. Symmetry related caffeine units pack parallel to each other with an inter-ring separation of 3.45 Å.